Swiss, U.K. researchers block faulty genes to slow ALS in mice

03/14/2005 | Times (London) (subscription required), The

In two separate trials, tests suggested that using gene therapy to interfere with a faulty SOD1 gene slowed the progression of a disease in mice similar to amyotrophic lateral sclerosis in humans. The teams used lentiviruses to deliver a healthy version of the gene to the mice to delay onset of the disease and prolong their lives, offering hope for a treatment for human sufferers of the degenerative disease, according to studies in Nature Medicine.

View Full Article in:

Times (London) (subscription required), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Principal Engineer - Service (US/MI/00/0043/SL) - 14000009CP
Abbott
Chicago, IL
Senior Manager, Compliance
Stryker
Fremont, CA
Manager, Business Conduct
Gilead
Foster City, CA
Product Patent Attorney
Gilead
Foster City, CA
Employment Counsel
Gilead
Foster City, CA